Allergic Rhinitis Chapter 11 PDF
Document Details
Uploaded by SoftNashville
PCOM School of Pharmacy
Tags
Summary
This document provides information on allergic rhinitis, including its symptoms, causes, and treatment options. It covers both pharmacological and non-pharmacological approaches to managing the condition, including allergen avoidance and various medications. The document also discusses special considerations for children and older adults.
Full Transcript
HergicRhinitis Chapter11 see Allergic rhinitis= systemic with prominent nasal symptoms, a ects upper respiratory tract **a ects 20% adults & 40% children in US Four phases: 1)Sensitization= Initial exposure, IgE production 2)Early= rapid release of mast cell mediator...
HergicRhinitis Chapter11 see Allergic rhinitis= systemic with prominent nasal symptoms, a ects upper respiratory tract **a ects 20% adults & 40% children in US Four phases: 1)Sensitization= Initial exposure, IgE production 2)Early= rapid release of mast cell mediators 3) Cellular recruitment= eisonophils come to nasal mucosa & cause in ammatory release 4) Late= mucus hypersensitivity & lower threshold Risk factors= family history, skin barrier, protein gene mutations, elevated IgE before age 6, higher socioeconomic class, eczema, and positive skin allergy test Triggers: -outdoor= pollen & diesel -indoor= dust, roaches, mold, smoke, pet dander -occupational= chemicals, latex, resin **Systemic antihistamines NOT recommended for kids 2-6 years old EXCEPT under advice of PCP -exception to this= cetirizine, fexofenadine, levocetirizine, loratidine **For adults >65 years ONLY loratidine allowed, BUT if under advice of PCP can use cetirizine, levocetirizine, & fexofenadine *Must rst classify person’s symptoms based on duration and severity Non-pharm: -allergen avoidance -outdoor= check pollen count, keep windows shut on days w/pollen, no yard work or outdoor sports -indoor= try to remove triggers (cat, mold, pets), lower humidity in home to reduce molds, wash bedding in hot water every week OTC-pharm: Antihistmines MOA= compete with histamine at central & peripheral histamine 1 receptor sites *preventing histamine receptor interaction & mediator release ~good for itching, sneezing, and runny nose (NOT nasal congestion) First Generation, non selective= sedating ~highly lipophilicity ~easily crosses BBB ~many drug interactions ~dangerous in high doses ~cardiac symptoms ~CNS symptoms (sedation, tremors, & sedation) -Chlorpheniramine (Chlor-Trimeton Allergy) -Clemastine (Tavist Allergy) -Diphenhydramine (Benadryl Allergy)= drug interactions with Phenytoin and Antacids -side e ects= CNS e ects, dry eyes, dry mucous membranes, urinary retention, & constipation Second Generation, peripherally selective= non-sedating -Cetirizine (Zyrtec) -Levocetirizine (Xyzal Allergy) -Loratidine (Claritin) -Fexofenadine (Allegra) -side e ects= more common with 1st gen. CNS (depression & stimulation) & anticholinergic e ects Intranasal Glucocorticoid: *good for itchy eyes and noses, sneezing, runny nose and congestion -Triamcinolone Acetonide (Nasacort)= approved for ≥2 years of age -Flonase (Fluticasone)= ONLY (treats nasal symptoms caused by allergic rhinitis), ≥4 years of age, shake bottle before use, minimal systemic absorption -side e ects= nasal discomfort, bleeding, or sneezing, change in vision, glaucoma, cataracts infection risk & growth inhibition -caution with growth inhibition in patients